Advertisement
Becton Dickinson
Subscribe to Becton Dickinson

The Lead

BD Launches New Point-of-Care System for HIV/AIDS Patients

April 24, 2014 9:26 am | by PR Newswire | News | Comments

BD Biosciences, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD FACSPresto Near Patient CD4 Counter system that provides absolute and percentage results of...

Diagnosing Group A Strep in Minutes with New Test

February 25, 2014 9:36 am | by PR Newswire | News | Comments

BD Diagnostics, a segment of BD, a leading global medical technology company, announced today...

BD Acquires Alverix

January 7, 2014 2:49 pm | by PR Newswire | News | Comments

BD, a leading global medical technology company, announced today that it has acquired Alverix,...

Zimmer, Abbott, others rake in hundreds of millions in fed contracts

September 26, 2013 4:17 pm | by Mass Device | News | Comments

Federal agencies have handed out a slew of contracts and contract extensions in recent weeks,...

View Sample

FREE Email Newsletter

BD Supports the FDA's Proposal to Reclassify Rapid Influenza Tests

August 26, 2013 9:32 am | by PR Newswire | News | Comments

BD, a leading global medical technology company, supports the U.S. Food and Drug Administration's (FDA's) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA's CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA's proposal to reclassify rapid influenza detection tests (RIDTs) currently regulated as Class I devices, into Class II devices.

Becton false advertising and antitrust lawsuit heads to trial

August 22, 2013 11:29 am | by Mass Device | News | Comments

Becton Dickinson & Co. (NYSE:BDX) is headed to court next month to speak to allegations, brought by rival Retractable Technologies' (NYSE:RVP), that it engaged in illegal in order to maintain a monopoly in the syringe business.  

BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement

April 26, 2013 2:19 pm | by Bio-Medicine.Org | News | Comments

SPARKS, Md. , April 27, 2013 /- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today an international distributor agreement with Bruker Daltonics Inc. to sell and provide front-line technical support for the co-labeled BD™ Bruker MALDI Biotyper™ System. Microbial identification and antimicrobial susceptibility testing is the end-poin...

Advertisement

Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.

February 21, 2013 8:01 am | by The Associated Press | News | Comments

Today, National Traders Association announced new research reports highlighting Bruker Corporation (NASDAQ: BRKR), Agilent Technologies Inc. (NYSE: A), General Electric Company (NYSE: GE), Becton, Dickinson and Co. (NYSE: BDX) and Thermo Fisher Scientific Inc. (NYSE: TMO). Today's readers...

BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care

September 19, 2012 12:06 pm | News | Comments

Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety[i-iii]. Patients who reported injection-related pain or embarrassment also admitted they intentionally skipped insulin injections more often. A study by the American Association of Diabetes Educators (AADE) revealed that...

BD Veritor System for Flu A+B Featuring Alverix Technology Receives Regulatory Approval in Japan

February 9, 2012 5:02 am | News | Comments

SAN JOSE, Calif.--(BUSINESS WIRE)--Alverix announced today that BD (Becton, Dickinson and Company) has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for the BD Veritorâ„¢ System Flu A+B Test. The BD Veritor System was developed...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading